SKYE – skye bioscience, inc. (US:NASDAQ)
Stock Stats
News
Skye Bioscience to Participate in Upcoming December Healthcare Investment Conferences
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor [Yahoo! Finance]
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor
Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights
Skye Bioscience Demonstrates Prominent Role of Peripheral CB1 Inhibition and Achieves Significant Weight Loss with Novel CB1-inhibiting Antibody, Nimacimab, in Preclinical Model
Form 4 Skye Bioscience, Inc. For: Nov 15 Filed by: Diep Tuan Tu
Form 4 Skye Bioscience, Inc. For: Nov 15 Filed by: ARSENAULT KAITLYN
Form 4 Skye Bioscience, Inc. For: Nov 15 Filed by: DHILLON PUNIT
Form 4 Skye Bioscience, Inc. For: Nov 15 Filed by: Grayson Paul A.
Form 144 Skye Bioscience, Inc. Filed by: ARSENAULT KAITLYN
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.